Bolt Biotherapeutics, Inc. (BOLT) stock
Close on Nov 12, 2026Market cap $11.38MP/E –Yield –
Bolt Biotherapeutics statistics
72 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- Q3 FY2026, expected soon
- Last ex-dividend date
- No dividends
- Fundamentals through
- Jun 30, 2026
- Share price as of
- Nov 12, 2026
Valuation ratiosIndustry
- P/TBV Ratio
- 0.90
- 2.29
Enterprise valuationIndustry
- EV / Sales
- -1.43
- 2.60
Share statisticsIndustry
- Shares Change (YoY)
- -8.42%
- 10.9%
- Shares Change (QoQ)
- 0.25%
- 0.48%
- Float
- 2M
- 49M
- Shares Held by Insiders
- 12.2%
- 12.1%
- Shares Held by Institutions
- 31.0%
- 56.4%
Short sellingIndustry
- Short Interest
- 47,382
- –
- Short Interest Change
- 200.8%
- -0.76%
- Short % of Float
- 2.80%
- 9.06%
- Short % of Shares Outstanding
- 2.46%
- 6.30%
- Days to Cover
- 1.00
- 5.13
Stock price statisticsIndustry
- 52-Week High
- $7.78
- –
- 52-Week Low
- $3.10
- –
- 20-Day Moving Average
- $5.83
- –
- 50-Day Moving Average
- $4.58
- –
- 200-Day Moving Average
- $4.50
- –
- Average True Range (14)
- $0.48
- –
- Price Change (1 Week)
- -7.37%
- 1.51%
- Price Change (1 Month)
- 48.5%
- -2.37%
- Price Change (3 Months)
- 76.4%
- -21.1%
- Price Change (6 Months)
- 18.2%
- -22.8%
- Price Change (YTD)
- 8.08%
- -22.6%
- Price Change (1 Year)
- 22.9%
- -21.0%
- Price Change (3 Years)
- -69.8%
- -24.8%
- Price Change (5 Years)
- -97.2%
- -76.9%
- Average Volume (10 Days)
- 117,537
- –
- Average Volume (20 Days)
- 746,433
- –
- Average Volume (90 Days)
- 186,503
- –
- Relative Volume
- 0.96
- 0.80
- Relative Strength Index (14)
- 56.0
- 44.7
- Volatility (1 Year)
- 88.5%
- 80.2%
- Beta (5 Years)
- 0.63
- 1.07
MarginsIndustry
- EBITDA Margin
- -635.0%
- -27.7%
Returns on capitalIndustry
- Return on Equity (ROE)
- -111.6%
- -51.3%
- Return on Assets (ROA)
- -49.6%
- -40.7%
- Return on Capital Employed (ROCE)
- -94.7%
- -38.1%
Financial positionIndustry
- Current Ratio
- 2.61
- 3.31
- Quick Ratio
- 2.30
- 2.41
GrowthIndustry
- Revenue Growth (YoY)
- 12.8%
- 7.26%
- Revenue Growth (3Y CAGR)
- 10.3%
- 2.25%
- Revenue Growth (5Y CAGR)
- 101.6%
- 6.41%
EfficiencyIndustry
- Asset Turnover
- 0.08
- 0.40
- Revenue Per Employee
- $204.35K
- $429.38K
- Profits Per Employee
- -$1.25M
- -$683.67K
- Employee Count
- 23
- 75
- WACC
- 8.01%
- 10.0%
Income statement (TTM)Industry
Balance sheetIndustry
- Net Cash (Debt)
- $18.10M
- $16.98M
- Net Cash Per Share
- $9.40
- $0.72
- Equity (Book Value)
- $12.64M
- $52.68M
- Book Value Per Share
- $6.56
- $1.50
- Tangible Book Value
- $12.64M
- $26.74M
- Working Capital
- $12.70M
- $78.52M
Cash flow (TTM)Industry
Dividends and yieldsIndustry
- Earnings Yield
- -252.4%
- -21.0%
- Buyback Yield
- -0.26%
- -0.73%
- Shareholder Yield
- -0.26%
- 0.00%
Scores and fair valueIndustry
- Altman Z-Score
- -18.28
- 0.26
- Piotroski F-Score
- 5
- 4
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.
| Period | BOLT | S&P 500 | Difference | BOLT per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +39.4% | -2.7% | +42.1 pts | ||
| 3 months | +71.3% | -1.7% | +73.1 pts | ||
| Year to date | +8.1% | +11.9% | −3.8 pts | ||
| 1 year | +26.0% | +12.0% | +14.0 pts | ||
| 3 years | -69.5% | +78.2% | −147.7 pts | -32.7% | +21.2% |
| 5 years | -97.2% | +73.2% | −170.4 pts | -51.0% | +11.6% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
0M BOLT shares were sold short on Oct 30, 2026, up 200.8% from the previous report, or 2.80% of the shares available to trade. At recent volumes it would take 1.0 days to buy them back. Over the last 20 sessions, 55.4% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 47,382 | +200.8% | 1,264,801 | 1.0 |
| Oct 15, 2026 | 15,751 | -38.8% | 26,150 | 1.0 |
| Sep 30, 2026 | 25,736 | +39.2% | 42,277 | 1.0 |
| Sep 15, 2026 | 18,486 | +18.7% | 30,445 | 1.0 |
| Aug 31, 2026 | 15,579 | +1923.2% | 17,581 | 1.0 |
| Aug 14, 2026 | 770 | -79.5% | 34,611 | 1.0 |
| Jul 31, 2026 | 3,749 | -34.9% | 12,715 | 1.0 |
| Jul 15, 2026 | 5,761 | -65.5% | 17,142 | 1.0 |
| Jun 30, 2026 | 16,698 | -38.7% | 39,560 | 1.0 |
| Jun 15, 2026 | 27,250 | +107.6% | 24,781 | 1.1 |
| May 29, 2026 | 13,125 | +8.2% | 34,638 | 1.0 |
| May 15, 2026 | 12,126 | +73.3% | 23,966 | 1.0 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?